Yardbarker on MSN

Evaluating Trade Deadline Acquisitions By Non-Playoff Teams

The Stanley Cup Playoffs are in full swing, but with half the league looking ahead, and more soon to join them, it’s time to ...

Celcuity: Best-In-Class Potential With 2-3x Upside If Mutant Data Delivers

Celcuity (CELC) cautious Buy: gedatolisib upside hinges on Q2 2026 mutant cohort data in 2L HR+/HER2- breast cancer.